Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 118,678 shares at $98.64 ($11.7M) on 2019-08-12, disclosed to the SEC on 2019-08-14.
Open-market sale of $11.7M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.48 | 5,309 | $512K | 4.4% |
| 2 | $97.61 | 17,105 | $1.7M | 14.2% |
| 3 | $98.64 | 45,010 | $4.4M | 37.9% |
| 4 | $99.58 | 51,254 | $5.1M | 43.5% |
| Total | $98.80 avg | 118,678 | $11.7M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |